BioSpace News Archive

BioMidwest

Vanqua Bio to Present at the Stifel 2023 CNS Day Conference

Vanqua Bio announced today that the company will participate in the Stifel 2023 CNS Day Conference, which is being held virtually March 28-29.

March 22, 2023
·
1 min read
Business

Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development

Syneos Health today announced a strategic partnership with KX, maker of kdb, the world’s fastest time series database and analytics engine.

March 22, 2023
·
4 min read
Business

OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time

OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter and full year 2022 financial results after the close of the U.S. financial markets on Wednesday, March 29th, 2023.

March 22, 2023
·
1 min read
Business

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

March 22, 2023
·
20 min read
Business

InflaRx Reports Full Year 2022 Financial and Operating Results

InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced financial and operating results for the year ended December 31, 2022.

March 22, 2023
·
19 min read
V-LAP Allows Heart Failure Patients to Self-Adjust Medication: Vectorious Reports Promising Findings From its Pilot Study at the THT meeting

Yesterday, Vectorious Medical Technologies Ltd. presented interim results from its Left Atrial Pressure (LAP) Guided, Patient Self-Management (PSM) pilot study during a featured abstract session at THT 2023 in Boston.

March 22, 2023
·
4 min read
Drug Development

Biohaven Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders

Biohaven Ltd. (NYSE: BHVN) today announced that it acquired global rights, excluding China regions, for the development of an oral, brain-penetrant, dual inhibitor of Tyrosine Kinase 2 (TYK2) and Janus Kinase 1 (JAK1) for the treatment of brain disorders.

March 22, 2023
·
8 min read
Pharm Country

ANNOVIS BIO ANNOUNCES TWO PRESENTATIONS AT THE AD/PD™ 2023 INTERNATIONAL CONFERENCE ON ALZHEIMER’S AND PARKINSON’S DISEASES

Annovis Bio, Inc. today announced the Company will be making two presentations at the upcoming AD/PD ™ 2023 International Conference on Alzheimer’s and Parkinson’s Disease, which is taking place from March 28 through April 1, 2023, in Gothenburg, Sweden.

March 22, 2023
·
6 min read
Business

Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, and Deerfield Management Company today announced a partnership to advance genetics-based drug discovery and development in rare disease.

March 22, 2023
·
5 min read
Business

BioBam Renews KEGG Pathway Licensing for OmicsBox

BioBam, a leading bioinformatics software company, announces the renewal of its KEGG license through a Business Provider Agreement with Pathway Solutions Inc., the exclusive worldwide licensing agent for KEGG resources.

March 22, 2023
·
3 min read